Japan Prescription Gastrointestinal Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Prescription Gastrointestinal Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Prescription Gastrointestinal Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Prescription Gastrointestinal Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • GlaxoSmithKline

    • AstraZeneca

    • Axcan Pharmaceuticals

    • Salix Pharmaceuticals

    • Eisai

    • Merck

    By Type:

    • Oral

    • Topical

    By End-User:

    • Hospital Pharmacies

    • Online Pharmacies

    • Retail Pharmacies

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Gastrointestinal Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2014 to 2026

      • 1.3.2 Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.2 Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

      • 1.4.3 Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Prescription Gastrointestinal Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Prescription Gastrointestinal Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Oral

      • 3.4.2 Market Size and Growth Rate of Topical

    4 Segmentation of Prescription Gastrointestinal Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Prescription Gastrointestinal Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Online Pharmacies

      • 4.4.3 Market Size and Growth Rate of Prescription Gastrointestinal Drugs in Retail Pharmacies

    5 Market Analysis by Regions

    • 5.1 Japan Prescription Gastrointestinal Drugs Production Analysis by Regions

    • 5.2 Japan Prescription Gastrointestinal Drugs Consumption Analysis by Regions

    6 Hokkaido Prescription Gastrointestinal Drugs Landscape Analysis

    • 6.1 Hokkaido Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 6.2 Hokkaido Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    7 Tohoku Prescription Gastrointestinal Drugs Landscape Analysis

    • 7.1 Tohoku Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 7.2 Tohoku Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    8 Kanto Prescription Gastrointestinal Drugs Landscape Analysis

    • 8.1 Kanto Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 8.2 Kanto Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    9 Chubu Prescription Gastrointestinal Drugs Landscape Analysis

    • 9.1 Chubu Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 9.2 Chubu Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    10 Kinki Prescription Gastrointestinal Drugs Landscape Analysis

    • 10.1 Kinki Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 10.2 Kinki Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    11 Chugoku Prescription Gastrointestinal Drugs Landscape Analysis

    • 11.1 Chugoku Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 11.2 Chugoku Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    12 Shikoku Prescription Gastrointestinal Drugs Landscape Analysis

    • 12.1 Shikoku Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 12.2 Shikoku Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    13 Kyushu Prescription Gastrointestinal Drugs Landscape Analysis

    • 13.1 Kyushu Prescription Gastrointestinal Drugs Landscape Analysis by Major Types

    • 13.2 Kyushu Prescription Gastrointestinal Drugs Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 AstraZeneca

      • 14.2.1 AstraZeneca Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Axcan Pharmaceuticals

      • 14.3.1 Axcan Pharmaceuticals Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Salix Pharmaceuticals

      • 14.4.1 Salix Pharmaceuticals Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Eisai

      • 14.5.1 Eisai Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Merck

      • 14.6.1 Merck Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 130 Figures and 181 Tables)

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Topical from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Prescription Gastrointestinal Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Prescription Gastrointestinal Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Prescription Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Oral

    • Figure Market Size and Growth Rate of Topical

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Prescription Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Prescription Gastrointestinal Drugs by Different End-Users from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Japan Prescription Gastrointestinal Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Table Japan Prescription Gastrointestinal Drugs Production by Regions

    • Table Japan Prescription Gastrointestinal Drugs Production Share by Regions

    • Figure Japan Prescription Gastrointestinal Drugs Production Share by Regions in 2014

    • Figure Japan Prescription Gastrointestinal Drugs Production Share by Regions in 2018

    • Figure Japan Prescription Gastrointestinal Drugs Production Share by Regions in 2026

    • Table Japan Prescription Gastrointestinal Drugs Consumption by Regions

    • Table Japan Prescription Gastrointestinal Drugs Consumption Share by Regions

    • Figure Japan Prescription Gastrointestinal Drugs Consumption Share by Regions in 2014

    • Figure Japan Prescription Gastrointestinal Drugs Consumption Share by Regions in 2018

    • Figure Japan Prescription Gastrointestinal Drugs Consumption Share by Regions in 2026

    • Table Hokkaido Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Hokkaido Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Hokkaido Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Hokkaido Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Tohoku Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Tohoku Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Tohoku Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Tohoku Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Tohoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Kanto Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Kanto Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Kanto Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Kanto Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Kanto Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Chubu Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Chubu Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Chubu Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Chubu Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Chubu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Kinki Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Kinki Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Kinki Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Kinki Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Kinki Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Chugoku Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Chugoku Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Chugoku Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Chugoku Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Chugoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Shikoku Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Shikoku Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Shikoku Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Shikoku Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Shikoku Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Kyushu Prescription Gastrointestinal Drugs Consumption by Types from 2014 to 2026

    • Table Kyushu Prescription Gastrointestinal Drugs Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by Types in 2014

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by Types in 2018

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by Types in 2026

    • Table Kyushu Prescription Gastrointestinal Drugs Consumption by End-Users from 2014 to 2026

    • Table Kyushu Prescription Gastrointestinal Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2014

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2018

    • Figure Kyushu Prescription Gastrointestinal Drugs Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Axcan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Axcan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Axcan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Axcan Pharmaceuticals

    • Table Product and Service Introduction of Axcan Pharmaceuticals

    • Table Company Profile and Development Status of Salix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

    • Table Product and Service Introduction of Salix Pharmaceuticals

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.